Общедоступные статьи - Megan B. MurrayПодробнее...
4 статьи недоступны нигде
Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study
MC Becerra, SC Appleton, MF Franke, K Chalco, F Arteaga, J Bayona, ...
The Lancet 377 (9760), 147-152, 2011
Финансирование: US National Institutes of Health
Culture-negative TB: Clinical characteristics, risk factors and treatment outcomes
F Okoya, CC Huang, Z Zhang, L Lecca, R Calderón, C Contreras, ...
The International Journal of Tuberculosis and Lung Disease 27 (7), 557-563, 2023
Финансирование: US National Institutes of Health
Multimodal Profiling of 500,000 Memory T Cells from a Tuberculosis Cohort Identifies Cell State Associations with Demographics, Environment, and Disease
A Nathan, J Beynor, Y Baglaenko, S Suliman, K Ishigaki, S Asgari, ...
Финансирование: US National Institutes of Health
Potential role of latent tuberculosis infection in the pathophysiology of cardiovascular disease
AL Chu, MB Murray, CC Huang
Clinical Infectious Diseases 74 (5), 943-944, 2022
Финансирование: US National Institutes of Health
173 статьи доступны в некоторых источниках
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
K Dheda, T Gumbo, G Maartens, KE Dooley, R McNerney, M Murray, ...
The lancet Respiratory medicine 5 (4), 291-360, 2017
Финансирование: US National Institutes of Health, UK Medical Research Council
Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis
MR Farhat, BJ Shapiro, KJ Kieser, R Sultana, KR Jacobson, TC Victor, ...
Nature genetics 45 (10), 1183-1189, 2013
Финансирование: Swiss National Science Foundation, US National Institutes of Health
Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis
CB Ford, RR Shah, MK Maeda, S Gagneux, MB Murray, T Cohen, ...
Nature genetics 45 (7), 784-790, 2013
Финансирование: US National Institutes of Health, Howard Hughes Medical Institute, Doris …
Interpreting Expression Data with Metabolic Flux Models: Predicting Mycobacterium tuberculosis Mycolic Acid Production
C Colijn, A Brandes, J Zucker, DS Lun, B Weiner, MR Farhat, TY Cheng, ...
PLoS computational biology 5 (8), e1000489, 2009
Финансирование: US National Institutes of Health
Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis
K Dheda, T Gumbo, NR Gandhi, M Murray, G Theron, Z Udwadia, ...
The lancet Respiratory medicine 2 (4), 321-338, 2014
Финансирование: US National Institutes of Health
A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis
P Miotto, B Tessema, E Tagliani, L Chindelevitch, AM Starks, C Emerson, ...
European Respiratory Journal 50 (6), 2017
Финансирование: Bill & Melinda Gates Foundation, European Commission, Government of Spain …
Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing
CRyPTIC Consortium and the 100,000 Genomes Project
New England Journal of Medicine 379 (15), 1403-1415, 2018
Финансирование: Bill & Melinda Gates Foundation, US National Institutes of Health, Chinese …
Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis
KR Jacobson, DB Tierney, CY Jeon, CD Mitnick, MB Murray
Clinical infectious diseases 51 (1), 6-14, 2010
Финансирование: US National Institutes of Health
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study
HH Lin, M Murray, T Cohen, C Colijn, M Ezzati
The Lancet 372 (9648), 1473-1483, 2008
Финансирование: US National Institutes of Health
Tuberculosis and poverty: why are the poor at greater risk in India?
O Oxlade, M Murray
PloS one 7 (11), e47533, 2012
Финансирование: Canadian Institutes of Health Research
The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis
L Martinez, O Cords, CR Horsburgh, JR Andrews, C Acuna-Villaorduna, ...
The Lancet 395 (10228), 973-984, 2020
Финансирование: Bill & Melinda Gates Foundation, US National Institutes of Health, UK …
Towards universal health coverage: an evaluation of Rwanda Mutuelles in its first eight years
C Lu, B Chin, JL Lewandowski, P Basinga, LR Hirschhorn, K Hill, ...
PloS one 7 (6), e39282, 2012
Финансирование: US National Institutes of Health, Doris Duke Charitable Foundation
Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation
NA Menzies, T Cohen, HH Lin, M Murray, JA Salomon
PLoS medicine 9 (11), e1001347, 2012
Финансирование: US National Institutes of Health
Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinants
JD Goldhaber-Fiebert, CY Jeon, T Cohen, MB Murray
International journal of epidemiology 40 (2), 417-428, 2011
Финансирование: US National Institutes of Health
A comparative lipidomics platform for chemotaxonomic analysis of Mycobacterium tuberculosis
E Layre, L Sweet, S Hong, CA Madigan, D Desjardins, DC Young, ...
Chemistry & biology 18 (12), 1537-1549, 2011
Финансирование: US National Institutes of Health
Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment
MF Franke, SC Appleton, J Bayona, F Arteaga, E Palacios, K Llaro, ...
Clinical infectious diseases 46 (12), 1844-1851, 2008
Финансирование: US National Institutes of Health
Информация о публикациях и финансировании собрана автоматически.